127 related articles for article (PubMed ID: 34686295)
1. Academic Detailing to Increase Prescribing of HIV Pre-exposure Prophylaxis.
Krakower DS; Naja-Riese GM; Edelstein ZR; Gandhi AD; Wahnich A; Fischer MA
Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S87-S97. PubMed ID: 34686295
[TBL] [Abstract][Full Text] [Related]
2. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
[TBL] [Abstract][Full Text] [Related]
3. Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis.
Ard KL; Edelstein ZR; Bolduc P; Daskalakis D; Gandhi AD; Krakower DS; Myers JE; Keuroghlian AS
Clin Infect Dis; 2019 Feb; 68(5):860-864. PubMed ID: 30020422
[TBL] [Abstract][Full Text] [Related]
4. Public Health Detailing to Promote HIV Pre- and Postexposure Prophylaxis Among Women's Healthcare Providers in New York City.
Wahnich A; Gandhi AD; Cleghorn E; Estacio K; Blackstock OJ; Myers JE; Abraham B; Edelstein ZR
Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S98-S107. PubMed ID: 34686296
[TBL] [Abstract][Full Text] [Related]
5. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
[TBL] [Abstract][Full Text] [Related]
6. Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic.
Hoffman JD; Shayegani R; Spoutz PM; Hillman AD; Smith JP; Wells DL; Popish SJ; Himstreet JE; Manning JM; Bounthavong M; Christopher MLD
J Am Pharm Assoc (2003); 2020; 60(6):e95-e99. PubMed ID: 32747164
[TBL] [Abstract][Full Text] [Related]
7. An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S.
Clement ME; Seidelman J; Wu J; Alexis K; McGee K; Okeke NL; Samsa G; McKellar M
AIDS Care; 2018 May; 30(5):650-655. PubMed ID: 28971705
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and acceptability of virtual academic detailing on opioid prescribing.
Smart MH; Mandava MR; Lee TA; Pickard AS
Int J Med Inform; 2021 Mar; 147():104365. PubMed ID: 33360790
[TBL] [Abstract][Full Text] [Related]
9. Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three U.S. Veterans Health Administration regional networks.
Bounthavong M; Shayegani R; Manning JM; Marin J; Spoutz P; Hoffman JD; Harvey MA; Himstreet JE; Kay CL; Freeman BA; Almeida A; Christopher MLD
Int J Med Inform; 2022 May; 161():104712. PubMed ID: 35196600
[TBL] [Abstract][Full Text] [Related]
10. Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.
Adeagbo O; Harrison S; Qiao S; Li X
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574652
[TBL] [Abstract][Full Text] [Related]
11. Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.
Silapaswan A; Krakower D; Mayer KH
J Gen Intern Med; 2017 Feb; 32(2):192-198. PubMed ID: 27761767
[TBL] [Abstract][Full Text] [Related]
12. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
Mullins TLK; Zimet G; Lally M; Xu J; Thornton S; Kahn JA
AIDS Patient Care STDS; 2017 Dec; 31(12):504-516. PubMed ID: 29211514
[TBL] [Abstract][Full Text] [Related]
13. Are We Prescribing Enough HIV Pre-Exposure Prophylaxis in Missouri?: A Cross-Sectional Study at University of Missouri Health Care.
Abu-Khalaf S; Dent J; Teti M; Dandachi D
Mo Med; 2020; 117(6):563-568. PubMed ID: 33311790
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a pharmacy-led virtual academic detailing program at the US Veterans Health Administration.
Himstreet JE; Shayegani R; Spoutz P; Hoffman JD; Midboe AM; Hillman A; Marin J; Chen A; Smith JP; Manning JM; Almeida A; Gray CP; Erhardt TA; Garcia CC; Freeman BA; Christopher MLD; Bounthavong M
Am J Health Syst Pharm; 2022 May; 79(11):909-917. PubMed ID: 35084487
[TBL] [Abstract][Full Text] [Related]
15. Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region.
Mullins TLK; Idoine CR; Zimet GD; Kahn JA
J Adolesc Health; 2019 May; 64(5):581-588. PubMed ID: 30578115
[TBL] [Abstract][Full Text] [Related]
16. Bringing Iowa TelePrEP to Scale: A Qualitative Evaluation.
Chasco EE; Shafer C; Dillon DMB; Owens S; Ohl ME; Hoth AB
Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S108-S117. PubMed ID: 34686280
[TBL] [Abstract][Full Text] [Related]
17. Influence of pharmaceutical promotion on prescribers in Jordan.
Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
[TBL] [Abstract][Full Text] [Related]
18. A pilot study evaluating alternative approaches of academic detailing in rural family practice clinics.
Hartung DM; Hamer A; Middleton L; Haxby D; Fagnan LJ
BMC Fam Pract; 2012 Dec; 13():129. PubMed ID: 23276303
[TBL] [Abstract][Full Text] [Related]
19. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
Okoro O; Hillman L
J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
[TBL] [Abstract][Full Text] [Related]
20. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
